Insellar sits at the edge of psychiatric neuromodulation and bioelectronic medicine, using a minimally invasive interface concept to engage endogenous hormone-release pathways in treatment-resistant depression. Its positioning is notable for linking neuroendocrine modulation with severe psychiatry at a preclinical stage.